(Q60211787)
Statements
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells (English)
Evgeny Kulesskiy
Jaya Sangodkar
Anna Aakula
Sudeh Izadmehr
Pekka Haapaniemi
Michael Ohlmeyer
Jukka Westermarck
eaaq1093
0 references